Showing results (81-90 of 245) with videos related to
Sort By:
Pageof 25
Vascular Pharmacology|March 29, 2017
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient miceHotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.Clinical and Experimental Nephrology|May 20, 2026
Platelet indices and incident CKD in high-risk individualsKenichi Tanaka, Hiroshi Kimura, Hirotaka Saito, et al.Nephrology (Carlton, Vic.)|May 21, 2026
Resting Heart Rate and Incident CKD Among Individuals With CKD Risk FactorsHirotaka Saito, Kenichi Tanaka, Hiroshi Kimura, et al.Journal of Computer Assisted Tomography|May 1, 2024
Respiratory Displacement of the Right Adrenal Vein: Comparison of Inspiratory and Expiratory Computed Tomography With Catheter VenographyJunko Hara, Shiro Ishii, Hayato Tanabe, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 28, 2020
Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON TrialHiroki Teragawa, Takeshi Morimoto, Yuichi Fujii, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 10, 2022
Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON TrialHiroki Teragawa, Takeshi Morimoto, Yuichi Fujii, et al.The Journal of Clinical Investigation|December 16, 2004
Increased oxidative stress in obesity and its impact on metabolic syndromeShigetada Furukawa, Takuya Fujita, Michio Shimabukuro, et al.The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Hypoadiponectinemia is closely linked to endothelial dysfunction in manMichio Shimabukuro, Namio Higa, Tomohiro Asahi, et al.International Heart Journal|April 24, 2015
Elevated Concentration of Interferon-Inducible Protein of 10 kD (IP-10) Is Associated With Coronary AtherosclerosisToshiyuki Niki, Takeshi Soeki, Koji Yamaguchi, et al.Diabetes, Obesity & Metabolism|October 4, 2022
Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trialSatoshi Yamaguchi, Michio Shimabukuro, Atsushi Tanaka, et al.Pageof 25